After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. The stock was recently discussed on Yahoo Finance as it revealed that BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
As a NASDAQ listed company, BNTX falls under the Healthcare sector while operating within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $93.57 and fluctuated between $94.45 as its day high and $92.41 as its day low. The current market capitalization of BioNTech SE ADR is $22.24B. A total of 0.57 million shares were traded on the day, compared to an average of 713.37K shares.
Dividend
Investors prefer companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook. BNTX’s most recent ex-dividend date was 6/2/2022 when it declared a $1.5342 quarterly dividend that was paid in cash on 6/17/2022.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for BNTX in the last 3 months, the mean price target is $117.25 with high estimates of $174.02 and low estimates of $90.73. In terms of 52-week highs and lows, BNTX has a high of $138.51 and a low of $88.00.
As of this writing, BNTX has an earnings estimate of $2.58 per share for the current quarter. EPS was calculated based on a consensus of 11 estimates, with a high estimate of $3.8 per share and a lower estimate of $0.86. The company reported an EPS of -$0.83 in the last quarter, which was 17.80% higher than expectations of -$1.01.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. BNTX’s latest balance sheet shows that the firm has $2.07B in Cash & Short Term Investments as of fiscal 2021. There were $301.50M in debt and $3.48B in liabilities at the time. Its Book Value Per Share was $88.48, while its Total Shareholder’s Equity was $11.89B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BNTX is Buy with a score of 3.62.
